- +144.1% price growth over the last year
- +126.9% YTD performance
- Low bankruptcy risk (Altman Z-Score: 4.29)
Moderna stock upgraded from Hold/Accumulate to Strong Buy Candidate after Tuesday trading session
(Updated on Jun 30, 2026)
The Moderna stock price gained 0.473% on the last trading day (Tuesday, 30th Jun 2026), rising from $69.70 to $70.03. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.87% from a day low at $69.22 to a day high of $73.28. The price has risen in 7 of the last 10 days and is up by 34.34% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 763 thousand more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $607.99 million.
The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $64.84, a level that may pose a second chance to hit a runner. According to fan-theory $82.06 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
MRNA Signals & Forecast
Mostly positive signals in the chart today. The Moderna stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $63.93 and $52.65. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 22, 2026, and so far it has risen 17.99%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Moderna stock
On the downside, the stock finds support just below today's level from accumulated volume at $63.96 and $54.35. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Moderna finds support just below today's level at $63.96. If this is broken, then the next support from accumulated volume will be at $54.35 and $52.88.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $4.06 between high and low, or 5.87%. For the last week, the stock has had daily average volatility of 7.99%.
The Moderna stock is extremely overbought on RSI14 (80). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stop-loss: $67.65 (-3.40%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 80 and this increases the risk substantially. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (MRNA) For The Upcoming Trading Day Of Wednesday 1st
For the upcoming trading day on Wednesday, 1st we expect Moderna Inc. to open at $70.84, and during the day (based on 14 day Average True Range), to move between $67.83 and $72.23, which gives a possible trading interval of +/-$4.41 (+/-6.50%) up or down from last closing price. If Moderna Inc. takes out the full calculated possible swing range there will be an estimated 6.50% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $63.96, some $6.07 (8.67%) from the current price of $70.03, our system finds the risk reward attractive.
Is Moderna Inc. stock A Buy?
Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Moderna stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.
Current score:
6.594
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 1, 2026 - $70.84 ( 1.16%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
MRNA Performance
Trading levels for MRNA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 74.90 | 6.96% |
| R2 | 73.35 | 4.74% |
| R1 | 72.39 | 3.38% |
| Price | 70.03 | |
| S1 | 69.29 | -1.05% |
| S2 | 68.33 | -2.42% |
| S3 | 66.78 | -4.64% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 70.03 | |
| S1 | 63.96 | -8.67% |
| S2 | 54.35 | -22.39% |
| S3 | 52.88 | -24.49% |
FAQ
Click here for our free guide on how to buy Moderna Stock.
Buy MRNA